Invention Application
- Patent Title: MICROFLUIDIC CHIP FOR SCREENING ANTICANCER DRUG RESISTANT CELLS AND USE THEREOF
-
Application No.: US15573924Application Date: 2016-05-13
-
Publication No.: US20180290138A1Publication Date: 2018-10-11
- Inventor: Sungsu PARK , Sanghyuk LEE
- Applicant: RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY , EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION
- Applicant Address: KR Suwon-si, Gyeonggi-do KR Seoul
- Assignee: RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY,EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION
- Current Assignee: RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY,EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION
- Current Assignee Address: KR Suwon-si, Gyeonggi-do KR Seoul
- Priority: KR10-2015-0068217 20150515
- International Application: PCT/KR2016/005108 WO 20160513
- Main IPC: B01L3/00
- IPC: B01L3/00 ; G01N33/50
Abstract:
The present invention relates to a microfluidic chip for screening anticancer drug resistant cells and a method for inducing or screening anticancer drug resistance using the same. The microfluidic chip of the present invention can induce a continuous concentration gradient between cell culture chambers and can implement the prompt induction and read-out within a week, unlike in existing read-out techniques, and thus, is expected to be able to take a target treatment through more fundament approach, in the treatment of cancer.
Information query
IPC分类:
